Statement of Use

PTO Form 1553 (Rev 4/2000)

OMB Control #0651-0009 (Exp. 06/30/2005)

---

PTO Form 1553 (Rev 4/2000)

OMB Control #0651-0009 (Exp. 06/30/2005)

Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: SUTENT
SERIAL NUMBER: 76388649

This Allegation of Use is being filed after a Notice of Allowance has issued.

The applicant, Pfizer Inc., residing at 235 East 42nd Street , New York, NY US 10017, is using or is using through a related company or licensee the mark in commerce on or in connection with the goods and/or services as follows:

For International Class: 005, the applicant, or the applicant's related company or licensee, is using the mark in commerce on or in connection with all goods and/or services listed in the application or Notice of Allowance, except the following: cardiovascular disorders, central nervous system diseases and disorders, neurological disorders, urological disorders, urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations.
The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 10/20/2004, and first used in commerce at least as early as 10/20/2004, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) product label`.
Specimen-1

The applicant hereby appoints Cindy M. Zelson to submit this Statement of Use Filing on behalf of the applicant.

A fee payment in the amount of $100 will be submitted with the form, representing payment for 1 class.


Declaration

Applicant requests registration of the above-identified trademark/service mark in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq., as amended). Applicant is the owner of the mark sought to be registered, and is using the mark in commerce on or in connection with the goods/services identified above, as evidenced by the attached specimen(s) showing the mark as used in commerce.

The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Cindy M. Zelson/      Date: 12/07/2004
Signatory's Name: Cindy M. Zelson
Signatory's Position: Senior Trademark Counsel, Pfizer Inc.

RAM Sale Number: 70
RAM Accounting Date: 12/08/2004

Serial Number: 76388649
Internet Transmission Date: Tue Dec 07 15:12:08 EST 2004
TEAS Stamp: USPTO/SOU-XXX.XX.XXX.X-20041207151208975
077-76388649-200d2dc66510595ed04ec318aa6
6aadff-RAM-70-20041203130956773288


Go Back